Figure 1.
Total number of enrollment, randomization, follow-up, and inclusion in the final analysis comparing among three treatment groups.
Table 1.
Demographic and baseline clinical features of the three study groups.
Table 2.
Comparison of symptoms related to chronic strongyloidiasis and baseline laboratory results.
Figure 2.
Kaplan-Meier Plot comparing the parasitological cure among the albendazole, ivermectin-I, and ivermectin-II treatment groups over one year follow-up period.
Table 3.
Outcome of treatment among the three study groups.
Table 4.
Summary of published controlled trials of oral ivermectin treatment for chronic strongyloidiasis.